News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
39.79
+0.64 (+1.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Structure Therapeutics Inc. - American Depositary Shares
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Monday's Intraday Session
June 03, 2024
Via
Benzinga
Obesity Data From Structure Therapeutics Shows Potential For Weight Loss Drug Candidate
June 03, 2024
Structure Therapeutics announces Phase 2a results for GSBR-1290, showing significant weight loss in obesity study.
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
June 03, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing
May 31, 2024
Sometimes the next big thing stocks to buy and hold are flying well under the radar. Here are three to consider.
Via
InvestorPlace
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the stock a significant upside potential.
Via
Benzinga
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024
May 09, 2024
GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
May 09, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
May 09, 2024
The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.
Via
InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
7 Small-Cap Stocks that Wall Street Loves for Good Reason
March 30, 2024
As small-cap stocks start to catch up to the market rally, it's time to look at seven small-cap stocks that Wall Street loves.
Via
InvestorPlace
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q4 2023
March 15, 2024
GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
March 08, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
March 08, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
The Best-Performing U.S. IPOs Of 2023
February 04, 2024
In 2023, there were 154 IPOs on the U.S. stock market. Here is a look at some of the best initial public offerings from last year.
Via
Talk Markets
IPO watch 2024: Which new stocks will hit the market?
January 08, 2024
Expectations are high for the 2024 IPO market, with Reddit, Databricks, and Shein debuts anticipated, hinting at a substantial influx of new public companies.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
January 05, 2024
Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.
Via
Investor's Business Daily
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
December 25, 2023
It has genuine struggles ahead, but it has some actual value in hand as well.
Via
The Motley Fool
7 Small-Cap Stocks That Wall Street Loves for Good Reason
December 22, 2023
The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading
Via
InvestorPlace
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
December 22, 2023
Despite a Wednesday tumble, the major indexes are right at 2023 highs.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 19, 2023
Via
Benzinga
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher
December 18, 2023
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 18, 2023
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
December 18, 2023
Via
Benzinga
Crude Oil Rises 3%; US Housing Market Index Increases In December
December 18, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Novo Nordisk's Potential Obesity Drug Rival Structure Therapeutics Stock Tanking Today?
December 18, 2023
Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development program update for its highly selective oral GLP-1
Via
Benzinga
Dow Gains Over 50 Points; Nippon Steel To Acquire U. S. Steel
December 18, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.15% to 37,362.28 while the NASDAQ rose...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Structure Stock Takes A Brutal Beating After Obesity Drug Trails Lilly's Leader
December 18, 2023
The company is hoping to break into the pack with an oral GLP-1 agonist.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.